2026-2030年全球家庭靜脈輸液治療中心市場

全球門診輸液中心市場預計將從 2025 年到 2030 年成長至 160.863 億美元，預測期內複合年成長率為 5.6%。

這份關於全球門診靜脈輸液治療中心市場的報告提供了全面的分析，包括市場規模和預測、趨勢、成長要素、挑戰以及涵蓋約 25 家供應商的供應商分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。推動該市場成長的因素包括：慢性複雜疾病盛行率的上升、經濟壓力、向更具成本效益的門診護理模式的轉變、靜脈輸液設備的科技進步以及與數位醫療的融合。

本研究客觀地結合了一手和二手訊息，包括主要行業相關人員的意見。報告內容涵蓋主要公司分析、全面的市場規模數據、細分市場數據及區域分析，以及供應商格局數據。此外，報告還包含歷史數據和預測數據。

本研究指出，未來幾年，專業輸液網路的擴張和分散式門診護理模式的推廣將是全球門診輸液中心市場成長的關鍵促進因素。此外，數位健康生態系統的整合、自動化庫存管理、生物相似藥製劑的廣泛應用以及保險覆蓋範圍的擴大，預計也將顯著提升市場需求。

目錄

第1章：執行摘要

第2章 Technavio 分析

• 分析定價、生命週期、顧客購買籃子、採用率和購買標準。
• 輸入的重要性及差異化因素
• 干擾因素
• 促進因素和挑戰的影響

第3章 市場狀況

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場的定義
• 市場區隔分析
• 2025年市場規模
• 市場展望，2025-2030年

第5章 市場規模與表現

• 2020-2024年全球家庭輸液中心市場
• 按類型分類的細分市場分析，2020-2024 年
• 2020-2024年基於適應症的細分市場分析
• 基於治療的細分市場分析，2020-2024 年
• 區域區隔市場分析，2020-2024 年
• 2020-2024年各國細分市場分析

第6章 定性分析

• 人工智慧的影響：全球家庭輸液中心市場
• 地緣政治衝突的影響：全球家庭靜脈輸液治療中心市場。

第7章：五力分析

第8章 市場區隔：依類型

• 比較：按類型
• 獨立中心
• 醫院
• 家庭醫療保健
• 市場機會：按類型分類

第9章 市場區隔：按適應症

• 比較：按指標
• 腫瘤學
• 自體免疫疾病
• 感染疾病
• 神經病變
• 慢性疼痛疾病
• 市場機會：依適應症分類

第10章 市場區隔：依療法

• 比較：按療法
• 免疫球蛋白療法
• 抗感染疾病治療
• 其他
• 市場機會：依療法分類

第11章 客戶情況

第12章 區域情勢

• 區域細分
• 區域比較
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
• 亞洲
  • 中國
  • 日本
  • 印度
  • 韓國
  • 台灣
  • 新加坡
• 世界其他地區（RoW）
  • 巴西
  • 沙烏地阿拉伯
  • 南非
  • 阿根廷
  • UAE
  • 紐西蘭
  • 智利
  • 埃及
• 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第14章 競爭格局

• 概述
• 競爭格局
• 混亂局面
• 產業風險

第15章 競爭分析

• 公司簡介
• 公司排名指標
• 企業市場定位
• Cedars Sinai Health System
• Community Health Systems Inc.
• CVS Health Corp.
• HCA Healthcare Inc.
• IVX Health
• Mayo Clinic
• McKesson Corp.
• Northwestern Medicine
• Option Care Health Inc.
• Sutter Health
• Tenet Healthcare Corp.
• The Cigna Group
• The Cleveland Clinic Foundation
• The Johns Hopkins Health System
• United Health Group Inc.

第16章附錄

The global ambulatory infusion center market is forecasted to grow by USD 16086.3 mn during 2025-2030, accelerating at a CAGR of 5.6% during the forecast period. The report on the global ambulatory infusion center market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of chronic diseases and complex conditions, economic pressures and shift toward cost-effective outpatient settings, technological advancements in infusion devices and digital health integration.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global ambulatory infusion center market is segmented as below:

By Type

• Independent centers
• Hospitals
• Home healthcare

By Indication

• Oncology
• Autoimmune disorders
• Infectious diseases
• Neurological disorders
• Chronic pain conditions

By Therapy

• Immunoglobulin therapy
• Anti-infective therapy
• Others

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the expansion of dedicated specialty infusion networks and decentralized outpatient care models as one of the prime reasons driving the global ambulatory infusion center market growth during the next few years. Also, integration of digital health ecosystems and automated inventory management and rising adoption of biosimilar therapeutics and expanded payer coverage frameworks will lead to sizable demand in the market.

The report on the global ambulatory infusion center market covers the following areas:

• Global ambulatory infusion center market sizing
• Global ambulatory infusion center market forecast
• Global ambulatory infusion center market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global ambulatory infusion center market vendors that include Cedars Sinai Health System, Community Health Systems Inc., CVS Health Corp., HCA Healthcare Inc., Infusion for Health, IVX Health, Mayo Clinic, McKesson Corp., Metro Infusion Center, Northwestern Medicine, Option Care Health Inc., Sutter Health, Tenet Healthcare Corp., The Cigna Group, The Cleveland Clinic Foundation, The Johns Hopkins Health System, United Health Group Inc.. Also, the global ambulatory infusion center market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by Indication
  • Executive Summary - Chart on Market Segmentation by Therapy
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Ambulatory Infusion Center Market 2020 - 2024
  • Historic Market Size - Data Table on Global Ambulatory Infusion Center Market 2020 - 2024 ($ million)
• 5.2 Type segment analysis 2020 - 2024
  • Historic Market Size - Type Segment 2020 - 2024 ($ million)
• 5.3 Indication segment analysis 2020 - 2024
  • Historic Market Size - Indication Segment 2020 - 2024 ($ million)
• 5.4 Therapy segment analysis 2020 - 2024
  • Historic Market Size - Therapy Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global ambulatory infusion center market
• 6.2 Impact of geopolitical conflicts on global ambulatory infusion center market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Type

• 8.1 Market segments
• 8.2 Comparison by Type
• 8.3 Independent centers - Market size and forecast 2025-2030
• 8.4 Hospitals - Market size and forecast 2025-2030
• 8.5 Home healthcare - Market size and forecast 2025-2030
• 8.6 Market opportunity by Type
  • Market opportunity by Type ($ million)

9 Market Segmentation by Indication

• 9.1 Market segments
• 9.2 Comparison by Indication
• 9.3 Oncology - Market size and forecast 2025-2030
• 9.4 Autoimmune disorders - Market size and forecast 2025-2030
• 9.5 Infectious diseases - Market size and forecast 2025-2030
• 9.6 Neurological disorders - Market size and forecast 2025-2030
• 9.7 Chronic pain conditions - Market size and forecast 2025-2030
• 9.8 Market opportunity by Indication
  • Market opportunity by Indication ($ million)

10 Market Segmentation by Therapy

• 10.1 Market segments
• 10.2 Comparison by Therapy
• 10.3 Immunoglobulin therapy - Market size and forecast 2025-2030
• 10.4 Anti-infective therapy - Market size and forecast 2025-2030
• 10.5 Others - Market size and forecast 2025-2030
• 10.6 Market opportunity by Therapy
  • Market opportunity by Therapy ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Taiwan - Market size and forecast 2025-2030
  • 12.5.6 Singapore - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 South Africa - Market size and forecast 2025-2030
  • 12.6.4 Argentina - Market size and forecast 2025-2030
  • 12.6.5 UAE - Market size and forecast 2025-2030
  • 12.6.6 New Zealand - Market size and forecast 2025-2030
  • 12.6.7 Chile - Market size and forecast 2025-2030
  • 12.6.8 Egypt - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Rising prevalence of chronic diseases and complex conditions
  • Economic pressures and shift toward cost-effective outpatient settings
  • Technological advancements in infusion devices and digital health integration
• 13.2 Market challenges
  • Complex and restrictive reimbursement frameworks
  • Severe workforce shortages and specialized staffing limitations
  • Intense competition and regulatory compliance burdens
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Expansion of dedicated specialty infusion networks and decentralized outpatient care models
  • Integration of digital health ecosystems and automated inventory management
  • Rising adoption of biosimilar therapeutics and expanded payer coverage frameworks

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Cedars Sinai Health System
  • Cedars Sinai Health System - Overview
  • Cedars Sinai Health System - Product / Service
  • Cedars Sinai Health System - Key offerings
  • SWOT
• 15.5 Community Health Systems Inc.
  • Community Health Systems Inc. - Overview
  • Community Health Systems Inc. - Product / Service
  • Community Health Systems Inc. - Key offerings
  • SWOT
• 15.6 CVS Health Corp.
  • CVS Health Corp. - Overview
  • CVS Health Corp. - Business segments
  • CVS Health Corp. - Key offerings
  • CVS Health Corp. - Segment focus
  • SWOT
• 15.7 HCA Healthcare Inc.
  • HCA Healthcare Inc. - Overview
  • HCA Healthcare Inc. - Product / Service
  • HCA Healthcare Inc. - Key offerings
  • SWOT
• 15.8 IVX Health
  • IVX Health - Overview
  • IVX Health - Product / Service
  • IVX Health - Key offerings
  • SWOT
• 15.9 Mayo Clinic
  • Mayo Clinic - Overview
  • Mayo Clinic - Product / Service
  • Mayo Clinic - Key offerings
  • SWOT
• 15.10 McKesson Corp.
  • McKesson Corp. - Overview
  • McKesson Corp. - Business segments
  • McKesson Corp. - Key offerings
  • McKesson Corp. - Segment focus
  • SWOT
• 15.11 Northwestern Medicine
  • Northwestern Medicine - Overview
  • Northwestern Medicine - Product / Service
  • Northwestern Medicine - Key offerings
  • SWOT
• 15.12 Option Care Health Inc.
  • Option Care Health Inc. - Overview
  • Option Care Health Inc. - Product / Service
  • Option Care Health Inc. - Key offerings
  • SWOT
• 15.13 Sutter Health
  • Sutter Health - Overview
  • Sutter Health - Product / Service
  • Sutter Health - Key offerings
  • SWOT
• 15.14 Tenet Healthcare Corp.
  • Tenet Healthcare Corp. - Overview
  • Tenet Healthcare Corp. - Business segments
  • Tenet Healthcare Corp. - Key offerings
  • Tenet Healthcare Corp. - Segment focus
  • SWOT
• 15.15 The Cigna Group
  • The Cigna Group - Overview
  • The Cigna Group - Business segments
  • The Cigna Group - Key offerings
  • The Cigna Group - Segment focus
  • SWOT
• 15.16 The Cleveland Clinic Foundation
  • The Cleveland Clinic Foundation - Overview
  • The Cleveland Clinic Foundation - Product / Service
  • The Cleveland Clinic Foundation - Key offerings
  • SWOT
• 15.17 The Johns Hopkins Health System
  • The Johns Hopkins Health System - Overview
  • The Johns Hopkins Health System - Product / Service
  • The Johns Hopkins Health System - Key offerings
  • SWOT
• 15.18 United Health Group Inc.
  • United Health Group Inc. - Overview
  • United Health Group Inc. - Business segments
  • United Health Group Inc. - Key offerings
  • United Health Group Inc. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations